Where is BOC Sciences located?

BOC Sciences is headquartered in Shirley, United States.

How many employees does BOC Sciences have?

As of May 31, 2026, the latest employee count at BOC Sciences is 22.

Is BOC Sciences a funded company?

BOC Sciences is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does BOC Sciences rank among its competitors?

BOC Sciences ranks 99th amongst 816 active competitors, of which 55 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Alloy Therapeutics, which secured $40M in Mar, 2026.

Who are the top competitors of BOC Sciences?

BOC Sciences' top competitors include Alloy Therapeutics, Maiva Pharma and Simulations Plus. Among them, Alloy Therapeutics secured the most recent funding round in March, 2026.

BOC Sciences - 2026 Company Profile, Team & Competitors

BOC Sciences is an unfunded company based in Shirley (United States), founded by Mindy One. It operates as a Global supplier of high-quality research chemicals and custom synthesis services. BOC Sciences has not raised any funding yet. The company has 816 active competitors, including 55 funded and 49 that have exited. Its top competitors include companies like Alloy Therapeutics, Maiva Pharma and Simulations Plus.

Company Details

Global supplier of high-quality research chemicals and custom synthesis services. The company provides a wide range of products including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP products, impurities, metabolites, APIs, natural compounds, ADCs, stem cell molecules, and chiral compounds. Services include custom synthesis, strain engineering, fermentation, bioconjugation, analytical services, antibody-drug conjugate development, target protein degradation platform, liposome and drug delivery, and RNAi therapy support. They serve academia, pharmaceuticals, biotech, CDMO, material sciences, and the agriculture industry, offering a one-stop solution for outsourcing needs. The company focuses on small molecule synthesis, biosynthesis, purification, and characterization, supporting drug discovery and development with innovative chemistry and global impact.

Website: bocsci.com/
Social
Email ID: *****@bocsci.com
Phone Number: +1 **********

Key Metrics

Location

Shirley, United States

Stage

Unfunded

Ranked

99^th among 816 active competitors

Employee Count

22 as on May 31, 2026

Similar Companies

Alloy Therapeutics & 837 more

View BOC Sciences' full profile

BOC Sciences has not raised any funding rounds yet.

The founders of BOC Sciences is Mindy One.

Here are the details of BOC Sciences' key team members:

Mindy One: Founder of BOC Sciences.

View details of BOC Sciences's Founder profiles and Board Members

BOC Sciences' employee count trend

BOC Sciences has 22 employees as of May 26. Here is BOC Sciences's employee count trend over the years:

Uncover BOC Sciences' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of BOC Sciences include Alloy Therapeutics, Maiva Pharma and Simulations Plus. Here is the list of Top 10 competitors of BOC Sciences, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Alloy Therapeutics 2017, Lexington (United States), Series E	Provider of drug discovery services	$157M	8VC, Mubadala & 11 others	63/100
2nd	Maiva Pharma 1996, Hosur (India), Late Stage	Manufacturer of sterile injectables	$125M	Nhpea V Spear, Nano-Vista & 25 others	61/100
3rd	Simulations Plus 1996, Lancaster (United States), Public	Developer of modeling and simulation software and consulting services provider	-	FDA, NIH & 1 others	60/100
4th	Manifold Bio 2018, United States, Series A	Developer of tissue-targeted therapeutics using in vivo screening and AI design	$78.2M	Playground Global, Triatomic & 8 others	58/100
5th	CILcare 2014, Montpellier (France), Series A	Service to develop health products aiming to diagnose, prevent, delay the progression or treat hearing loss and tinnitus	$42.3M	Shionogi, Galia Gestion & 5 others	53/100
6th	VelaVigo 2021, Shanghai (China), Seed	Biotechnology research company developing biological drugs	$160M	Shunwei Capital, Panacea Venture & 17 others	53/100
7th	ArcaScience 2018, Paris (France), Seed	Developer of AI models for patient-centric insights in drug development	$7M	The Moon Venture, Bpifrance & 4 others	52/100
8th	Biocom California 1995, San Diego (United States), Acquired	CRO focused on drug discovery & development for multiple therapeutic areas	-	-	52/100
9th	Syenex 2022, Chicago (United States), Series B	Developer of cell-specific delivery systems and programmable cell engineering payloads	$13.7M	AlleyCorp, KdT Ventures	51/100
10th	Viva Biotech 2006, Shanghai (China), Public	Research services focused on drug discovery and development	-	Temasek, Spinnotec & 3 others	51/100
99th	BOC Sciences Shirley (United States), Unfunded	Global supplier of high-quality research chemicals and custom synthesis services	-	-	28/100